US STOCK
GSK Stock Analysis
US stocks · market data · technical indicators
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
GSKUS stocksQuote delayed 15 min
10/26 下午06:38 updated
$50.75
-0.46-0.90%
Open
$50.83
High
$50.92
Low
$50.29
Volume
317.91萬
GSK price history
+2.11%Open
49.70
Latest
50.75
High
51.21
Low
46.27
Average
48.32
Advertisement
Financial snapshot
GSK - GSK plc
EPS
3.17USD
Forward EPS
4.94USD
P/E
16.01x
Forward P/E
10.28x
P/B
4.30x
ROE
33.38%
ROA
10.01%
Operating margin
30.94%
Profit margin
14.52%
Revenue growth
5.30%
Earnings growth
-69.50%
Dividend yield
3.58%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $8.41B | $7.63B | $8.62B | $8.55B | $7.99B |
| Gross profit | $6.14B | $5.75B | $5.96B | $6.29B | $5.82B |
| Operating income | $481.00M | $2.29B | $1.51B | $2.59B | $2.02B |
| Net income | $435.00M | $1.74B | $636.00M | $2.01B | $1.44B |
| Basic EPS | 0.22 | 0.86 | 0.32 | 1.00 | 0.71 |
| Diluted EPS | 0.21 | 0.85 | 0.31 | 0.98 | 0.70 |
Estimates vs actuals
Next earnings
2026-10-28
EPS estimate
1.33
Revenue estimate
$8.83B
Last surprise
+7.24%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-28 | 1.33 | Not reported | — |
| 2026-07-28 | 1.25 | 1.34 | +7.24% |
| 2026-04-29 | 1.16 | 1.26 | +7.88% |
| 2026-02-04 | 0.62 | 0.70 | +11.93% |
| 2025-10-29 | 1.26 | 1.46 | +15.37% |
| 2025-07-30 | 1.11 | 1.24 | +11.73% |
| 2025-04-30 | 1.04 | 1.20 | +15.64% |
| 2025-02-05 | 0.49 | 0.58 | +18.80% |
| 2024-10-30 | 1.16 | 1.29 | +10.97% |
| 2024-07-31 | 0.98 | 1.11 | +13.17% |
| 2024-05-01 | 0.94 | 1.08 | +15.13% |
| 2024-01-31 | 0.77 | 0.73 | -4.51% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| STATE STREET CORP | 2026-06-30 | $315.1M | 0.01% |
| BlackRock Inc. | 2024-06-30 | $64.7M | 0.00% |
| Bridgewater Associates, LP | 2026-06-30 | $26.4M | 0.11% |
| CITADEL ADVISORS LLC | 2026-06-30 | $7.9M | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $3.7M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$60.51
Target range
$49.00 – $70.00
Implied upside
19.24%
Strong buy
1
Buy
3
Hold
4
Sell
1
Strong sell
0
Dividends
Annual yield
3.52%
Frequency
Quarterly
Recent payouts
- 2026-08-14$0.4426
- 2026-05-15$0.4475
- 2026-02-20$0.4701
- 2025-11-14$0.4256
Advertisement